|
covid-19 |
47 |
|
chinese |
40 |
|
children |
36 |
|
coronavirus |
19 |
|
child psychosocial problems |
16 |
|
healthcare workers |
16 |
|
home confinement |
16 |
|
hospital policies |
16 |
|
perceived stress |
16 |
|
psychological wellbeing |
16 |
|
school closure |
16 |
|
cytokines |
13 |
|
immunoglobulin |
13 |
|
lymphocyte subsets |
13 |
|
sars |
13 |
|
false positive |
12 |
|
kawasaki disease |
12 |
|
serology |
12 |
|
hong kong |
11 |
|
allergy |
10 |
|
asparaginase |
10 |
|
human leukocyte antigens |
10 |
|
hypersensitivity |
10 |
|
infants |
10 |
|
vitamin d |
10 |
|
age-stratified |
9 |
|
asia |
9 |
|
travel history |
9 |
|
abdominal pain |
8 |
|
antimicrobial resistance |
8 |
|
bacteria |
8 |
|
covid‐19 |
8 |
|
diagnosis |
8 |
|
diarrhoea |
8 |
|
meningitis |
8 |
|
nanopore sequencing |
8 |
|
neonates |
8 |
|
nsp1 |
8 |
|
paediatric gastroenterology |
8 |
|
rt‐pcr |
8 |
|
sars‐cov‐2 |
8 |
|
cervical screening |
7 |
|
covid-19 pandemic |
7 |
|
hpv vaccination |
7 |
|
immunological profiles |
7 |
|
physical activity |
7 |
|
saliva |
7 |
|
school closures |
7 |
|
school-aged children |
7 |
|
screen time |
7 |
|
sexual behaviour |
7 |
|
sleep |
7 |
|
viral load |
7 |
|
adolescence |
6 |
|
asthma |
6 |
|
bnt162b2 |
6 |
|
coronavac |
6 |
|
cox regression |
6 |
|
down syndrome |
6 |
|
inborn errors of immunity |
6 |
|
mortality |
6 |
|
population-based study |
6 |
|
retrospective cohort |
6 |
|
rhinitis |
6 |
|
snoring |
6 |
|
telomere length |
6 |
|
vaccine |
6 |
|
adulthood |
5 |
|
bmi |
5 |
|
child maltreatment |
5 |
|
chinese children |
5 |
|
cord blood |
5 |
|
cytokine |
5 |
|
exercise |
5 |
|
family support |
5 |
|
hospital |
5 |
|
infection control |
5 |
|
inflammation |
5 |
|
interrupted time series |
5 |
|
mother-offspring dyad |
5 |
|
paediatrics |
5 |
|
physical fitness |
5 |
|
policy |
5 |
|
pregnancy |
5 |
|
reference values |
5 |
|
serum 25-hydroxyvitamin d |
5 |
|
stress |
5 |
|
supplementation |
5 |
|
adolescent |
4 |
|
covid-19 vaccines |
4 |
|
dress |
4 |
|
drug reaction with eosinophilia and systemic symptoms |
4 |
|
drug-induced hypersensitivity syndrome |
4 |
|
echocardiography |
4 |
|
health resources |
4 |
|
hospitalisation |
4 |
|
immunology |
4 |
|
isolation |
4 |
|
magnetic resonance imaging |
4 |
|
myocarditis |
4 |
|
paediatric |
4 |
|
primary immunodeficiencies |
4 |
|
resource needs |
4 |
|
sars-cov-2 |
4 |
|
standard of care |
4 |
|
stool |
4 |
|
treatment outcome |
4 |
|
agammaglobulinemia |
3 |
|
amputation |
3 |
|
anti-nmda receptor encephalitis |
3 |
|
atherosclerosis - etiology |
3 |
|
cardiovascular diseases - etiology |
3 |
|
cardiovascular risk factors |
3 |
|
claudication |
3 |
|
component resolved diagnostics |
3 |
|
gangrene |
3 |
|
homozygous c4b deficiency |
3 |
|
inborn error of immunity |
3 |
|
peanut allergy |
3 |
|
peripheral arterial disease |
3 |
|
peripheral arterial disease - etiology - surgery |
3 |
|
plasmapheresis |
3 |
|
severe acute respiratory syndrome (sars) |
3 |
|
skin prick test |
3 |
|
vitamin d - blood |
3 |
|
vitamin d deficiency |
3 |
|
vitamin d deficiency - complications |
3 |
|
x-linked lymphoproliferative disease type 1 (xlp1) |
3 |
|
adrenaline |
2 |
|
anaphylaxis |
2 |
|
autoinjector |
2 |
|
clinical feature |
2 |
|
consensus |
2 |
|
consortium |
2 |
|
diagnostic accuracy |
2 |
|
exposure variable |
2 |
|
fish |
2 |
|
canada |
1 |
|
elderly |
1 |
|
falls |
1 |
|
home |
1 |
|
long-term care |
1 |
|
oit |
1 |
|
preschooler |
1 |
